User profiles for "author:Mark Obermann"

Mark Obermann

Verified email at uni-due.de
Cited by 21092

Advances in diagnosis, classification, pathophysiology, and management of trigeminal neuralgia

L Bendtsen, JM Zakrzewska, TB Heinskou… - The Lancet …, 2020 - thelancet.com
Trigeminal neuralgia is a very painful neurological condition with severe, stimulus-evoked,
short-lasting stabbing pain attacks in the face. The past decade has offered new insights into …

[HTML][HTML] Vestibular migraine: the most frequent entity of episodic vertigo

M Dieterich, M Obermann, N Celebisoy - Journal of neurology, 2016 - Springer
Vestibular migraine (VM) is the most common cause of episodic vertigo in adults as well as
in children. The diagnostic criteria of the consensus document of the International Bárány …

Red and orange flags for secondary headaches in clinical practice: SNNOOP10 list

TP Do, A Remmers, HW Schytz, C Schankin… - Neurology, 2019 - AAN Enterprises
A minority of headache patients have a secondary headache disorder. The medical
literature presents and promotes red flags to increase the likelihood of identifying a …

European Academy of Neurology guideline on trigeminal neuralgia

L Bendtsen, JM Zakrzewska, J Abbott… - European journal of …, 2019 - Wiley Online Library
Background and purpose Trigeminal neuralgia (TN) is an extremely painful condition which
can be difficult to diagnose and treat. In Europe, TN patients are managed by many different …

Prevalence of trigeminal neuralgia and persistent idiopathic facial pain: a population-based study

D Mueller, M Obermann, MS Yoon, F Poitz… - …, 2011 - journals.sagepub.com
Objective: To estimate the lifetime prevalence of trigeminal neuralgia (TN) and persistent
idiopathic facial pain (PIFP) in a population-based sample in Germany. Methods: A total of …

[HTML][HTML] HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment

C Eggers, G Arendt, K Hahn, IW Husstedt… - Journal of …, 2017 - Springer
The modern antiretroviral treatment of human immunodeficiency virus (HIV-1) infection has
considerably lowered the incidence of opportunistic infections. With the exception of the …

Treatment options in trigeminal neuralgia

M Obermann - Therapeutic advances in neurological …, 2010 - journals.sagepub.com
The incidence of trigeminal neuralgia (TN) is 4.3 per 100,000 persons per year, with a
slightly higher incidence for women (5.9/100,000) compared with men (3.4/100,000). There …

Gray matter volume reduction reflects chronic pain in trigeminal neuralgia

M Obermann, R Rodriguez-Raecke, S Naegel, D Holle… - Neuroimage, 2013 - Elsevier
Trigeminal neuralgia (TN) is supposedly caused by an ectatic blood vessel affecting the
trigeminal nerve at the root entry zone of the brain stem. Recent evidence suggests an …

Assessment, diagnosis, and treatment of HIV-associated neurocognitive disorder: a consensus report of the mind exchange program

Mind Exchange Working Group… - Clinical Infectious …, 2013 - academic.oup.com
Many practical clinical questions regarding the management of human immunodeficiency
virus (HIV)–associated neurocognitive disorder (HAND) remain unanswered. We sought to …

Safety and efficacy of a Nav1. 7 selective sodium channel blocker in patients with trigeminal neuralgia: a double-blind, placebo-controlled, randomised withdrawal …

JM Zakrzewska, J Palmer, V Morisset… - The Lancet …, 2017 - thelancet.com
Background Current standard of care for trigeminal neuralgia is treatment with the sodium
channel blockers carbamazepine and oxcarbazepine, which although effective are …